Covid-19 Hospitalisation Risk Factors in Patients With Anti-rheumatic Drugs Is No Way Different From Others
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
Researchers provide consensus recommendations on managing selected comorbidities in rheumatoid arthritis
Researchers validate the role of serum biomarkers in determining disease activity of ANCA-associated vasculitis
You must be logged in to post a comment.